LENZ Therapeutics Inc.

NASDAQ: LENZ
Share price (3/25/25): $26.43
Market cap (3/25/25): $728 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Prospectus supplement

Prospectus supplement

Prospectus supplement

Ownership Filter

Schimmelpennink Evert B.

Chevallard Daniel R.

Schimmelpennink Evert B.

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Reports Third Quarter 2024 Financial Results

CORXEL and LENZ Therapeutics Announce Positive Topline Data From China Phase 3 Presbyopia Trial of LNZ100

Reports Second Quarter 2024 Financial Results

Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC